Alpha Tau Medical Ltd.
DRTS
$10.88
-$0.29-2.60%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 3.03M | 2.64M | 2.14M | 2.74M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 12.60M | 9.65M | 9.31M | 10.27M | |
| Operating Income | -12.60M | -9.65M | -9.31M | -10.27M | |
| Income Before Tax | -12.17M | -10.05M | -8.59M | -9.47M | |
| Income Tax Expenses | -35.00K | 65.00K | 99.00K | 2.00K | |
| Earnings from Continuing Operations | -12.14M | -10.11M | -8.69M | -9.48M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -12.14M | -10.11M | -8.69M | -9.48M | |
| EBIT | -12.60M | -9.65M | -9.31M | -10.27M | |
| EBITDA | -12.29M | -9.38M | -9.03M | -10.00M | |
| EPS Basic | -0.14 | -0.13 | -0.12 | -0.14 | |
| Normalized Basic EPS | -0.09 | -0.08 | -- | -0.08 | |
| EPS Diluted | -0.14 | -0.13 | -0.12 | -0.14 | |
| Normalized Diluted EPS | -0.09 | -0.08 | -- | -0.08 | |
| Average Basic Shares Outstanding | 86.16M | 80.45M | 70.45M | 70.14M | |
| Average Diluted Shares Outstanding | 86.16M | 80.45M | 70.45M | 70.14M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |